RX for Pharma Industry Communications and Planning

Visit Eye on FDA

YouTube Warning Letter

Posted on September 29, 2008

A Warning Letter was posted by CDER's DDMAC on Friday, September 26 that was sent to Shire Pharmaceuticals regarding a Web promotion and a YouTube video for Adderall XR. While normally Warning Letters are not featured here except in a quarterly roundup, this one has significance since it involves a foray into YouTube by a pharmaceutical company promoting a product. Again, the lesson here is that it is the message, not the medium, that trips the regulatory tripwire. According to the FDA, there was both a webpage and a video promoting Adderall XR, both of which were said by the agency to ...

Original article link


adhd